Skip to main content
Premium Trial:

Request an Annual Quote

Protagen Closes Round of Financing

NEW YORK (GenomeWeb News) – Dortmund, Germany-based Protagen said today that it has closed a new round of financing with existing institutional investors MIG, S-Venture Capital Dortmund, and Kreditanstalt für Wiederaufbau.
 
The firm did not disclose how much money it raised in the financing, but said it would use proceeds to strengthen and expand its UNIarray technology position and development of diagnostics. The UNIarray is a platform for diagnostics based on autoantibody patterns, and is also used in companion diagnostics and patient stratification for clinical studies, the firm said.
 
The firm is working on tests for prostate cancer, multiple sclerosis, rheumatoid arthritis, juvenile idiopathic arthritis, Morbus Parkinson, and Alzheimer’s disease.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.